Physician

Jordan Bradford Heskett, M.D.

According to 2025 Medicare claims, Jordan Heskett, M.D. (NPI: 1811300098) practices dermatology in the Columbus, IN market, with the plurality of this provider's patient population coming from Bartholomew, IN. This provider's primary affiliated billing organization is DERMATOLOGY PHYSICIANS, INC. (NPI: 1932135241; TIN: 351178212) and primary practice location at 47201-2902. Heskett is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Heskett's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,088 traditional Medicare patients, billed 5,004 HCPCS/CPT codes, and received $230,451 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,797 prescription claims across 674 beneficiaries totaling $989,748 in drug costs, led by Cosentyx Unoready Pen (Secukinumab). Open Payments data shows 67 records totaling $1,298. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $109,750 to $230,451. Similarly, Part D prescription costs have moved sharply higher in recent years, from $8,463 to $989,748. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$116K$233K2018 Medicare payment: $109,750 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $179,281 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $174,041 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $232,714 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $188,899 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $205,276 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $230,451 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20186962,759$109,750
20199834,973$179,281
20208964,309$174,041
20219604,954$232,714
20229524,470$188,899
20231,0335,087$205,276
20241,0885,004$230,451

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$495K$990K2015 Drug cost: $8,463 (USD; Tot_Drug_Cst)2016 Drug cost: $7,403 (USD; Tot_Drug_Cst)2017 Drug cost: $6,535 (USD; Tot_Drug_Cst)2018 Drug cost: $23,946 (USD; Tot_Drug_Cst)2019 Drug cost: $205,508 (USD; Tot_Drug_Cst)2020 Drug cost: $322,147 (USD; Tot_Drug_Cst)2021 Drug cost: $394,056 (USD; Tot_Drug_Cst)2022 Drug cost: $599,289 (USD; Tot_Drug_Cst)2023 Drug cost: $968,729 (USD; Tot_Drug_Cst)2024 Drug cost: $989,748 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201551113$8,463
201651116$7,403
201744112$6,535
2018223436$23,946
20194361,050$205,508
20204461,117$322,147
20215021,196$394,056
20225091,309$599,289
20235771,615$968,729
20246741,797$989,748

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths253285$69
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7921,082$62
11102Biopsy of related skin growth, first growth332404$59
17000Destruction of precancer skin growth, 1 growth472608$34
17003Destruction of precancer skin growth, 2-14 growths3341,515$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Cosentyx Unoready PenSecukinumab27868$287,948
OtezlaApremilast341,020$165,291
Dupixent PenDupilumab361,148$130,813
FluorouracilFluorouracil1263,520$8,388
Clobetasol PropionateClobetasol Propionate1895,391$5,683

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.67$1,298Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jordan Bradford Heskett, M.D.?

Tedicare shows public-source Medicare data for Jordan Bradford Heskett, M.D. (NPI 1811300098), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jordan Bradford Heskett, M.D. have ACO affiliation data?

Jordan Bradford Heskett, M.D. is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Jordan Bradford Heskett, M.D.?

Jordan Bradford Heskett, M.D. is linked to DERMATOLOGY PHYSICIANS, INC. (billing NPI 1932135241) in the available physician profile data.

Does Jordan Bradford Heskett, M.D. have Open Payments data?

Jordan Bradford Heskett, M.D. has 67 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.